Insider Stock Trading History of Scheder-bieschin Max


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Scheder-bieschin Max since year 2005. The trader's CIK number is 1342549. At the time of this reporting, Scheder-bieschin Max is the Chief Financial Officer of Ekso Bionics Holdings, Inc. . (stock ticker symbol EKSO). See this page for all insider trading activities at Ekso Bionics Holdings, Inc. .

Note that in the past SCHEDER-BIESCHIN MAX also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Scheder-bieschin Max since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-07 EKSO Ekso Bionics Holdings, Inc. Buy 10,000 1.13 11,299
2016-11-11 EKSO Ekso Bionics Holdings, Inc. Buy 1,000 4.00 3,995
2007-05-22 ZAAP Zap Sale 4,000 1.13 4,520
2007-05-23 ZAAP Zap Option Ex 3,056 .59 1,803
2007-05-18 ZAAP Zap Sale 4,675 1.15 5,376
2007-05-18 ZAAP Zap Option Ex 15,278 .95 14,514
2007-05-23 ZAAP Zap Sale 9,659 1.13 10,914
2007-05-01 ZAAP Zap Option Ex 55,000 .81 44,550
2007-05-01 ZAAP Zap Sale 70,000 1.20 84,000
2007-04-23 ZAAP Zap Option Ex 19,861 .59 11,717
2007-04-24 ZAAP Zap Option Ex 55,000 .81 44,550
2007-04-23 ZAAP Zap Sale 3,000 1.22 3,660
2007-04-24 ZAAP Zap Sale 36,861 1.22 44,822
2007-04-25 ZAAP Zap Sale 20,000 1.21 24,180
2007-04-23 ZAAP Zap Sale 72,222 1.22 87,821
2007-04-23 ZAAP Zap Option Ex 72,222 .95 68,610
2007-04-20 ZAAP Zap Sale 50,000 1.16 57,999
2007-04-20 ZAAP Zap Option Ex 50,000 .95 47,500
2007-04-09 ZAAP Zap Sale 17,000 1.11 18,904
2007-03-21 ZAAP Zap Sale 20,000 .90 18,040

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Scheder-bieschin Max (Chief Financial Officer of Ekso Bionics Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.